Richard Aranda - Mar 16, 2023 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Chief Medical Officer
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Stock symbol
GOSS
Transactions as of
Mar 16, 2023
Transactions value $
-$8,304
Form type
4
Date filed
3/20/2023, 09:21 AM
Previous filing
Dec 9, 2022
Next filing
Mar 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GOSS Common Stock Sale -$8.3K -7.56K -3.65% $1.10 199K Mar 16, 2023 Direct F1, F2
holding GOSS Common Stock 2.54K Mar 16, 2023 By family trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $1.08 to $1.10 per share. The price reported above reflects the weighted average sale price for the entire number of shares sold. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.